---
category: news
title: "Deargen Signs Agreement With Sookmyung Women’s University Research & Business Development Foundation for Licensing ‘NASH Biomarker’ Technologies"
excerpt: "Deargen (President: Kilsoo Kang), an artificial intelligence (AI)-powered drug discovery and development company, announced on July 27 that it signed an agreement with Sookmyung Women’s University Research & Business Development Foundation for licensing biomarker technologies for determining the progression stage of NASH (non-alcoholic steatohepatitis) patients."
publishedDateTime: 2021-07-27T12:02:00Z
originalUrl: "https://www.cadillacnews.com/ap/business/deargen-signs-agreement-with-sookmyung-women-s-university-research-business-development-foundation-for-licensing-nash/article_c7517cda-62b6-5852-9fdb-cb79935f2286.html"
webUrl: "https://www.cadillacnews.com/ap/business/deargen-signs-agreement-with-sookmyung-women-s-university-research-business-development-foundation-for-licensing-nash/article_c7517cda-62b6-5852-9fdb-cb79935f2286.html"
type: article

provider:
  name: Cadillac Evening News
  domain: cadillacnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://bloximages.newyork1.vip.townnews.com/cadillacnews.com/content/tncms/assets/v3/editorial/9/9c/99cbdf74-f10f-5862-8632-2169689ed864/60fff9a210107.image.jpg?resize=1016%2C630"
    width: 1016
    height: 630
    isCached: true

secured: "8AqsHkpQl64/ii//dFDrUFvBOEsh4WpUKka3vIdE4UIMnUoxqeQmB1ZoMKVLLJJkzichmUXzp6RwF8zq5YqLaDnU5DOFMfyAcBBhH1eX25Zev5rvJxIkMvd9d4vOlhzZyAq0kv1qHR/XYeT2vekxWpSUvfEUaVUpmZ5J2rCPLVxHLhX3nGcLSRHZnbONKrLghds4FlHUVOMMpO2ySJsz+GqtBymR3OqwbSlc9W5figidY9IugoL2snEvhLNvglPXSpfXNaqOmLaWh32l0rsMmfs8/JXGFsA3Ok9wRa+M4AdQRwEVtK/kJ9UX9yXnBznrbDbtaCBka7knRwr7lLCTpjpRKM09SRSCKrb6Hl7JeQw=;JeQsznpl3s8CZlVhw2zO/g=="
---

